Mettler-Toledo International (NYSE:MTD) Upgraded to Buy at Wall Street Zen

Mettler-Toledo International (NYSE:MTD) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Monday.

Several other brokerages have also issued reports on MTD. The Goldman Sachs Group assumed coverage on Mettler-Toledo International in a report on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price target on the stock. Citigroup increased their target price on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Weiss Ratings restated a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 29th. Wells Fargo & Company raised their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the company an “equal weight” rating in a research note on Monday, December 15th. Finally, Bank of America raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 target price for the company in a research report on Monday, December 15th. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $1,441.67.

Mettler-Toledo International Stock Down 2.6%

Mettler-Toledo International stock opened at $1,457.91 on Monday. The company has a market capitalization of $29.79 billion, a PE ratio of 36.36, a PEG ratio of 4.34 and a beta of 1.41. Mettler-Toledo International has a 12-month low of $946.69 and a 12-month high of $1,525.17. The firm’s fifty day moving average is $1,432.83 and its 200 day moving average is $1,339.44.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, beating the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The firm had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $997.36 million. During the same period in the previous year, the firm posted $10.21 earnings per share. The business’s revenue was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Sell-side analysts expect that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, Director Elisha W. Finney sold 474 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $1,433.57, for a total transaction of $679,512.18. Following the transaction, the director owned 311 shares of the company’s stock, valued at $445,840.27. This trade represents a 60.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider La Guerroniere Marc De sold 6,055 shares of the business’s stock in a transaction that occurred on Tuesday, November 25th. The stock was sold at an average price of $1,488.18, for a total value of $9,010,929.90. Following the completion of the transaction, the insider owned 187 shares in the company, valued at $278,289.66. The trade was a 97.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 19,565 shares of company stock worth $28,683,737. Company insiders own 1.94% of the company’s stock.

Institutional Investors Weigh In On Mettler-Toledo International

Several large investors have recently made changes to their positions in MTD. Versant Capital Management Inc raised its stake in shares of Mettler-Toledo International by 42.1% during the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock worth $33,000 after purchasing an additional 8 shares during the period. SJS Investment Consulting Inc. raised its position in Mettler-Toledo International by 2,700.0% in the third quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 27 shares during the period. NewSquare Capital LLC raised its position in Mettler-Toledo International by 94.4% in the second quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock worth $41,000 after acquiring an additional 17 shares during the period. MV Capital Management Inc. boosted its stake in Mettler-Toledo International by 50.0% in the second quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock valued at $42,000 after acquiring an additional 12 shares during the last quarter. Finally, Root Financial Partners LLC bought a new position in shares of Mettler-Toledo International during the 3rd quarter valued at approximately $42,000. 95.07% of the stock is owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.